amiodarone has been researched along with Hyperthyroxinemia in 4 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Hyperthyroxinemia: Abnormally elevated THYROXINE level in the BLOOD.
| Excerpt | Relevance | Reference |
|---|---|---|
| " It revealed the pattern of euthyroid dysalbuminemic hyperthyroxinemia." | 7.69 | [Familial dysalbuminemic hyperthyroxinemia in long-term amiodarone treated patients]. ( Eber, B; Eber, O; Klein, W; Költringer, P; Langsteger, W; Prohaska, R; Sternad, H; Wawschinek, O, 1994) |
| "Examining the course of cardiac arrhythmias (CA) in developed TT has established that this condition gives rise to their recurrence." | 5.32 | [The specific features of thyrotoxicosis and euthyroid hyperthyroxinemia developed due to the use of cordarone]. ( Bakalov, SA; Domogadskiĭ, SP; Golitsyn, SP; Kolesnikova, GS; Masenko, VP; Molashenko, NV; Platonova, NM; Serdiuk, SE; Sviridenko, NIu, 2004) |
| "Examining the course of cardiac arrhythmias (CA) in developed TT has established that this condition gives rise to their recurrence." | 1.32 | [The specific features of thyrotoxicosis and euthyroid hyperthyroxinemia developed due to the use of cordarone]. ( Bakalov, SA; Domogadskiĭ, SP; Golitsyn, SP; Kolesnikova, GS; Masenko, VP; Molashenko, NV; Platonova, NM; Serdiuk, SE; Sviridenko, NIu, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goichot, B | 1 |
| Savagner, F | 1 |
| Sapin, R | 1 |
| Luca, F | 1 |
| Schlienger, JL | 1 |
| Molashenko, NV | 1 |
| Sviridenko, NIu | 1 |
| Platonova, NM | 1 |
| Kolesnikova, GS | 1 |
| Golitsyn, SP | 1 |
| Bakalov, SA | 1 |
| Serdiuk, SE | 1 |
| Masenko, VP | 1 |
| Domogadskiĭ, SP | 1 |
| Sternad, H | 1 |
| Eber, B | 1 |
| Langsteger, W | 1 |
| Prohaska, R | 1 |
| Költringer, P | 1 |
| Wawschinek, O | 1 |
| Klein, W | 1 |
| Eber, O | 1 |
| Tubman, R | 1 |
| Jenkins, J | 1 |
| Lim, J | 1 |
4 other studies available for amiodarone and Hyperthyroxinemia
| Article | Year |
|---|---|
Marked hyperthyroxinemia during amiodarone treatment revealing thyroid hormone resistance syndrome.
Topics: Amiodarone; Female; Humans; Hyperthyroxinemia; Internal Medicine; Iodine; Middle Aged; Phenotype; Th | 2008 |
[The specific features of thyrotoxicosis and euthyroid hyperthyroxinemia developed due to the use of cordarone].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Autoantibodies; Blood Flow Velocity; Elect | 2004 |
[Familial dysalbuminemic hyperthyroxinemia in long-term amiodarone treated patients].
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Female; Humans; Hyperthyroxinemia; Long-Term Care; Male; | 1994 |
Neonatal hyperthyroxinaemia associated with maternal amiodarone therapy: case report.
Topics: Adult; Amiodarone; Cardiac Complexes, Premature; Female; Humans; Hyperthyroxinemia; Infant, Newborn; | 1988 |